Fig. 2From: Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPCPCA score plots of the healthy participants and IPF patients of the pilot study measured in the (a) positive and (b) negative ESI modeBack to article page